ResMed unable to explain share price moves:
This article was originally published in Clinica
ResMed has responded to a request from the New York Stock Exchange (NYSE) concerning a steep rise and then a dramatic fall in its share price. The San Diego, California-based sleep disorder device company said that it was unaware of any corporate developments which could account for investor activities since February. The company has announced a two-for-one stock split to shareholders following what it calls a "record" last quarter.